Dermata Therapeutics (DRMA) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Dermata Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $13 of DRMA stock on the open market.
Get emailed when insiders cluster-buy stocks like DRMA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
DRMA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $13 | 1 |
| Q1 2026 | $1K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Dermata Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $13. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 16SEC | Kathleen D. ScottDirector | Sell | 11 | $1.19 | $13 | -14.3% | — |
| Mar 17SEC | Munera Maria E Bedoya-toroSvp, Regulatory Affairs | Buy | 1,0001,012 held (+8333%) | $1.27 | $1K | -19.7% | — |
Insiders at Dermata Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Munera Maria E Bedoya-toroSvp, Regulatory Affairs | $1K | — | Mar 17, 2026 | — |
| Kathleen D. ScottDirector | — | $13 | Jun 16, 2026 | — |
DRMA stock: common questions
Are Dermata Therapeutics, Inc. insiders buying DRMA stock?
In the past 12 months, 0 insiders reported open-market purchases of DRMA worth $0. The latest was Svp, Regulatory Affairs Munera Maria E Bedoya-toro bought $1K of DRMA at $1.27 — first open-market purchase in our records; raises the stake by 8333%.
Are Dermata Therapeutics, Inc. insiders selling DRMA stock?
1 insiders reported sales worth $13 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DRMA's 52-week range?
Over the past year DRMA has traded between $1.02 and $4.54. It last closed at $1.02 on Oct 9, 2026.